Lyell Immunopharma (LYEL) Q3 2024 Earnings

7AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.25
-0.17
-0.08
0

Details

Expected EPS
-0.1975
Actual EPS
-0.18
Surprise EPS
0.02
Surprise Percent
+8.86%

Description

Lyell Immunopharma (LYEL) has reported earnings of -0.18 per share for Q3 2024.

0 Comments

Share your thoughts